Serologic Testing for Rubella
Dr. Binnicker reviews the epidemiology of rubella and a patient case. Dr. Binnicker discusses how the conclusion that rubella is no longer endemic in the United States has changed the laboratory approach to diagnosis. As a result of these changes, Mayo Medical Laboratories has discontinued IgM-class antibody testing for rubella.
- Matt Binnicker, PhD, D(ABMM)) from the Division of Clinical Microbiology at Mayo Clinic
Forward to a Colleague
If you have questions, e-mail